Literature DB >> 6837230

Analgesic, respiratory and endocrine responses in normal man to THIP, a GABA-agonist.

T Lindeburg, S Følsgård, H Sillesen, E Jacobsen, H Kehlet.   

Abstract

In a controlled study, the effects of THIP (a synthetic gamma-aminobutyric-acid-agonist) on respiratory function (ventilatory response to CO2), first detection of stimulation (electrical stimulation of a tooth), pain threshold, magnitude of maximal tolerated pain stimulation, and plasma cortisol, prolactin and glucose were investigated in six normal men. Intramuscular injection of THIP in dosages of both 10 mg and 20 mg increased the magnitude of stimulus before first detection, and the pain threshold as well as the maximal tolerance of pain stimulation. THIP did not lead to changes in respiratory function, or in plasma cortisol, prolactin or glucose, suggesting an analgesic action independent of opiate receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837230     DOI: 10.1111/j.1399-6576.1983.tb01896.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  The analgesic effect of the GABA-agonist THIP in patients with chronic pain of malignant origin. A phase-1-2 study.

Authors:  M Kjaer; H Nielsen
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

2.  Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor.

Authors:  Delia Belelli; Derk Hogenkamp; Kelvin W Gee; Jeremy J Lambert
Journal:  Neurobiol Stress       Date:  2019-12-23

3.  Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic pain.

Authors:  Timothy B C Johnstone; Jennifer Y Xie; Chaoling Qu; David J Wasiak; Derk J Hogenkamp; Frank Porreca; Kelvin W Gee
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.